Daniel Marks is an Executive Group Medical Director in Early Clinical Development (Immunology) at AstraZeneca and serves as a Consultant Physician and Honorary Associate Professor at UCLH/UCL. From 2013 to 2018, they were a Specialist Registrar and Postdoctoral Research Fellow at University College London. Daniel held the position of Senior Medical Director at AstraZeneca in 2020-2021 before advancing to Executive Medical Director in Early Clinical Development (Immunology). They also served as Director of Discovery Medicine at GSK from 2018 to 2020 and have been an Honorary Associate Professor at UCL since 2021. Additionally, they have contributed as Executive Editor and now Senior Editor for the British Journal of Clinical Pharmacology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices